financial post
Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease
Financial Post • 4 MONTHS AGO
Daanaa Announces Zodiac Solar Power Substring Inverter Samples for PV Module Integration, Unlocking Up to 42% More Energy Harvest
Financial Post • 4 MONTHS AGO
Predictmedix AI Announces Closing of $320,000 First Tranche to Accelerate Commercialization
Financial Post • 4 MONTHS AGO
Purpose Investments Inc. Announces February 2025 Distributions for the Seven New Yield Shares ETFs
Financial Post • 4 MONTHS AGO
American Tungsten Announces Upsize of Non-Brokered LIFE Offering of Shares
Financial Post • 4 MONTHS AGO